Essex Financial Services, Inc. Edwards Lifesciences Corp Transaction History

Essex Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$86.5 - $128.27 $149,212 - $221,265	-1,725 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $23,401 - $28,749	-220 Reduced 11.31%	1,725 $223,000
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $24,698 - $29,460	-240 Reduced 10.98%	1,945 $220,000
Q2 2021 Jul 30, 2021	BUY	$83.84 - $104.76 $183,190 - $228,900	2,185 New	2,185 $226,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Essex Financial Services, Inc. with notifications on news.